Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao Sells 90,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $13.42, for a total transaction of $1,207,800.00. Following the completion of the transaction, the chief executive officer now directly owns 2,453,100 shares in the company, valued at $32,920,602. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Alignment Healthcare Trading Down 2.9 %

Shares of ALHC stock opened at $12.78 on Thursday. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $14.25. The firm’s fifty day simple moving average is $11.49 and its 200 day simple moving average is $9.28. The firm has a market capitalization of $2.45 billion, a P/E ratio of -16.60 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, meeting the consensus estimate of ($0.14). Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business had revenue of $692.43 million during the quarter, compared to analysts’ expectations of $662.11 million. During the same quarter last year, the company earned ($0.19) earnings per share. The firm’s revenue was up 51.6% on a year-over-year basis. As a group, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

ALHC has been the topic of several research reports. Robert W. Baird upped their price target on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. KeyCorp started coverage on Alignment Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. TD Cowen upped their price objective on shares of Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. Barclays lifted their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 30th. Finally, Piper Sandler reiterated an “overweight” rating and set a $10.00 price objective (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $10.33.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. nVerses Capital LLC acquired a new stake in Alignment Healthcare during the 3rd quarter valued at $95,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Alignment Healthcare in the third quarter valued at about $131,000. Virtu Financial LLC bought a new stake in Alignment Healthcare during the 1st quarter worth about $57,000. Creative Planning increased its position in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in shares of Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after purchasing an additional 2,077 shares during the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.